Lv5
1480 积分 2023-12-27 加入
Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
3个月前
已完结
Cefepime/Enmetazobactam: First Approval
3个月前
已完结
In vitro activity of cefepime-enmetazobactam on carbapenem resistant Gram negatives
3个月前
已完结
Population Pharmacokinetic Modeling for Ceftazidime‐Avibactam Renal Dose Adjustments in Pediatric Patients 3 months and Older
6个月前
已完结
Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae
6个月前
已完结
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study
6个月前
已完结
Tissue distribution of ceftazidime-avibactam in kidney tissue in healthy rats and pigs using a microdialysis technique
7个月前
已完结
Pharmacokinetic of ceftazidime‐avibactam in a critically ill patient under high‐volume continuous venovenous haemodiafiltration: A first paediatric case report
7个月前
已完结
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia
9个月前
已完结
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams
9个月前
已完结
皖公网安备34019202002308
